BioGaia (0GTN) Stock Overview
A healthcare company, provides probiotic products worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
0GTN Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
BioGaia AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 103.04 |
| 52 Week High | SEK 135.40 |
| 52 Week Low | SEK 93.63 |
| Beta | 0.62 |
| 1 Month Change | 2.12% |
| 3 Month Change | -10.17% |
| 1 Year Change | -17.17% |
| 3 Year Change | -2.40% |
| 5 Year Change | -3.52% |
| Change since IPO | 1,134.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0GTN | GB Biotechs | GB Market | |
|---|---|---|---|
| 7D | 4.8% | 1.7% | 0.4% |
| 1Y | -17.2% | -10.3% | 5.6% |
Return vs Industry: 0GTN underperformed the UK Biotechs industry which returned -10.3% over the past year.
Return vs Market: 0GTN underperformed the UK Market which returned 5.6% over the past year.
Price Volatility
| 0GTN volatility | |
|---|---|
| 0GTN Average Weekly Movement | 5.5% |
| Biotechs Industry Average Movement | 8.7% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in GB Market | 11.9% |
| 10% least volatile stocks in GB Market | 3.3% |
Stable Share Price: 0GTN has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0GTN's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 224 | Theresa Agnew | www.biogaiagroup.com |
BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula and milk formula.
BioGaia AB (publ) Fundamentals Summary
| 0GTN fundamental statistics | |
|---|---|
| Market cap | SEK 10.57b |
| Earnings (TTM) | SEK 309.74m |
| Revenue (TTM) | SEK 1.42b |
Is 0GTN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0GTN income statement (TTM) | |
|---|---|
| Revenue | SEK 1.42b |
| Cost of Revenue | SEK 385.91m |
| Gross Profit | SEK 1.03b |
| Other Expenses | SEK 723.54m |
| Earnings | SEK 309.74m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
Jul 18, 2025
| Earnings per share (EPS) | 3.06 |
| Gross Margin | 72.81% |
| Net Profit Margin | 21.83% |
| Debt/Equity Ratio | 0% |
How did 0GTN perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/30 07:41 |
| End of Day Share Price | 2025/06/27 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
BioGaia AB (publ) is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Christopher Uhde | ABG Sundal Collier Sponsored |
| Kristofer Liljeberg-Svensson | Carnegie Investment Bank AB |
| Mattias Häggblom | Danske Bank |